<DOC>
	<DOCNO>NCT01373359</DOCNO>
	<brief_summary>Sublingual misoprostol produce rapid peak concentration effective oral misoprostol prevention excessive postpartum bleeding . The study hypothesis test whether woman receive sublingual misoprostol prevention postpartum hemorrhage 30 ml less average blood loss woman receive oxytocin , standard care prevention postpartum hemorrhage . We conduct Double blind randomize controlled trial .652 consenting , eligible pregnant woman admit labor room teach hospital J N Medical College , Belgaum , India . Women participate study assign computer generate randomization receive study medication placebos within one minute clamp cut umbilical cord . We also look drug effect postpartum blood loss ≥500 ml ( consider hemorrhage ) , percent woman experience 10 % decline haemoglobin , report drug side effect .</brief_summary>
	<brief_title>Prevention Postpartum Haemorrhage With Sublingual Misoprostol Oxytocin</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Women gestational age &gt; 28weeks singleton pregnancy cephalic presentation anticipate normal spontaneous vaginal delivery ( include episiotomy ) haemoglobin ≥ 8g/dl upon presentation admit labour room KLE teach hospital attach J N Medical College , Belgaum Women pregnancy induce hypertension antepartum haemorrhage previous caesarean section presence uterine scar diagnose chorioamnionitis oxytocin induction augmentation labour intrauterine death diagnose medical disorder ( diabetes , cardiac , renal hepatic disease , etc . ) active labour ( define &gt; 4 cm dilatation )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Misoprostol , oxytocin , postpartum blood loss , hemoglobin</keyword>
</DOC>